IDEX Biometrics ASA

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

45173W105
SEDOL

B43BZJ1
CIK

N/A

idexbiometrics.com
LEI:
FIGI: -
IDEXO

IDEX Biometrics ASA
GICS: - · Sector: - · Sub-Sector: -
NAME
IDEX Biometrics ASA
ISIN
NO0003070609
TICKER
IDEXO
MIC
XOSL
REUTERS
IDEX.OL
BLOOMBERG
IDEX NO
EN 728x90
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
Three Short sale positions >= 0.50% are currently registered as reportable-relevant
Date Position Holder Position # Action
18.12.2023 GSA Capital Partners LLP 0,79% 19
14.12.2022 Bronte Capital Management Pty Ltd 0,50% 10
10.11.2021 Arrowstreet Capital, Limited Partnership 0,58% 3
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
Date Position Holder Position # Action
18.12.2023 GSA Capital Partners LLP 0,79% 19
14.12.2022 Bronte Capital Management Pty Ltd 0,50% 10
10.11.2021 Arrowstreet Capital, Limited Partnership 0,58% 3
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.